Genmab A/S Financial Overview
Genmab A/S's market cap is currently €17.50B. The company's EPS TTM is €5.4865024188; its P/E ratio is 13.29; Genmab A/S is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €3.62. See an overview of income statement, balance sheet, and cash flow financials.
